L'Institut de NeuroPhysiopathologie (INP) est un centre d'excellence pour la formation et la recherche qui allie la recherche fondamentale et translationnelle pour étudier l'organisation, la fonction et l'interaction des cellules neurales, les bases moléculaires et cellulaires des principales maladies du cerveau, et développer des stratégies de thérapies cellulaires et moléculaires innovantes.
La PFNT (Plateforme NeuroTimone) est un ensemble cohérent d'outils d'exploration en neurobiologie permettant des investigations aux échelles moléculaires, cellulaires et intégrées.
Because generation of patient avatar for preclinical therapeutic development is critically needed in neuro-oncology, the GlioME team in collaboration with the PETRA"TECH" platform developed an easy method to generate tumoroids from primary and metastatic brain tumors, including a dedicated 3D spatial analysis workflow for drug development.
Maud, Chiara, and Matthew (SynapTau team) are happy to announce the award of an ERC Starting Grant for the team, with the project set to begin in January 2025. The ERC project "SynApoE" aims to characterize how ApoE4 controls synaptic degeneration in Alzheimer's disease.
We invite you to celebrate this great news on September 23rd, during Maud's HDR celebration.
We look forward to sharing this moment with you!
We’re over the moon to see our latest work with Stéphane Vassilopoulos and his team published in Science. Check out how we reveal the unique architecture of clathrin-coated pits and endocytosis at the axon initial segment!
Comme chaque année les équipes 8, 9 et 10 de l’INP ont participé au Séminaire Annuel du Canceropôle qui se tenait au Palais des Congrès de Saint-Raphaël les 4 et 5 juillet 2024.
Congratulations to Chiara Bordier (team 2 SynapTau) for receiving the GBM (Association for Biochemistry and Molecular Biology) Master Prize for the best master’s thesis! This year, Professor Lichtenthaler from Technische Universität München and the DZNE presented this honour, marking the fourth time it has been awarded. Chiara's award-winning research explored the impact of Tau protein on nuclear organization and chromatin dynamics in neurodegenerative diseases, highlighting its crucial role in nuclear tension and stress response.
INP and Vect-Horus both participated to the symposium “Imagining the future of cancer treatments” (~100 participants) organized by the Translate-It departement of CRCM in Luminy. Along with keynote speaker Maria Kavallaris (Director of the Australian Centre for NanoMedicine at UNSW), François Devred gave an overview of INP's work on cancer entitle "How the INP contributes to the future of cancer treatments" and Pavlo Shpak-Kraievskyi of Vect-Horus gave a talk on "Surface modification of LNPs for brain targeting of nucleic acids".
Sofia (doctorante équipe 7), Charbel (doctorant équipes 3 et 9) et Jehanne (doctorante équipe 5) ont participé et présenté des posters à FENS 2024 à Vienne (Autriche). Ce fut une expérience enrichissante de discuter de leurs travaux avec leurs pairs, d'assister à des présentations sur des recherches novatrices dans nos domaines respectifs, et de déguster des plats typiques autrichiens avec d'autres membres de NeuroMarseille et d’ailleurs.
Rafael Godoy, recipient of the prestigious Eiffel Excellence Scholarship, recently started a two-month internship in the Neural Plasticity and Degeneration team. Originally from João Pessoa, Brazil, he is currently pursuing a Master's degree in Neurosciences at the Aix-Marseille University.
During his internship, he will be working on the effects of MT5-MMP on neuroinflammation and intracellular trafficking.
Because generation of patient avatar for preclinical therapeutic development is critically needed in neuro-oncology, the GlioME team in collaboration with the PETRA"TECH" platform developed an easy method to generate tumoroids from primary and metastatic brain tumors, including a dedicated 3D spatial analysis workflow for drug development.
Maud, Chiara, and Matthew (SynapTau team) are happy to announce the award of an ERC Starting Grant for the team, with the project set to begin in January 2025. The ERC project "SynApoE" aims to characterize how ApoE4 controls synaptic degeneration in Alzheimer's disease.
We invite you to celebrate this great news on September 23rd, during Maud's HDR celebration.
We look forward to sharing this moment with you!
We’re over the moon to see our latest work with Stéphane Vassilopoulos and his team published in Science. Check out how we reveal the unique architecture of clathrin-coated pits and endocytosis at the axon initial segment!
Comme chaque année les équipes 8, 9 et 10 de l’INP ont participé au Séminaire Annuel du Canceropôle qui se tenait au Palais des Congrès de Saint-Raphaël les 4 et 5 juillet 2024.
Congratulations to Chiara Bordier (team 2 SynapTau) for receiving the GBM (Association for Biochemistry and Molecular Biology) Master Prize for the best master’s thesis! This year, Professor Lichtenthaler from Technische Universität München and the DZNE presented this honour, marking the fourth time it has been awarded. Chiara's award-winning research explored the impact of Tau protein on nuclear organization and chromatin dynamics in neurodegenerative diseases, highlighting its crucial role in nuclear tension and stress response.
INP and Vect-Horus both participated to the symposium “Imagining the future of cancer treatments” (~100 participants) organized by the Translate-It departement of CRCM in Luminy.
Sofia (doctorante équipe 7), Charbel (doctorant équipes 3 et 9) et Jehanne (doctorante équipe 5) ont participé et présenté des posters à FENS 2024 à Vienne (Autriche). Ce fut une expérience enrichissante de discuter de leurs travaux avec leurs pairs, d'assister à des présentations sur des recherches novatrices dans nos domaines respectifs, et de déguster des plats typiques autrichiens avec d'autres membres de NeuroMarseille et d’ailleurs.
Rafael Godoy, recipient of the prestigious Eiffel Excellence Scholarship, recently started a two-month internship in the Neural Plasticity and Degeneration team. Originally from João Pessoa, Brazil, he is currently pursuing a Master's degree in Neurosciences at the Aix-Marseille University.
During his internship, he will be working on the effects of MT5-MMP on neuroinflammation and intracellular trafficking.
Aix Marseille Université | All rights reserved - Legal notice
